Through the secretion of cytokines, chemokines, and other effector molecules, including TGF-β, CXCL2, collagen, MMP, and laminin, CAFs can promote immune cells to participate in the occurrence and development of cancer, while promoting the degradation and remodeling of ECM (Ziani et al., 2018). This evidence concerns the gene TGFB1 and cancer.